Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1

Background: Non-alcoholic fatty liver disease (NAFLD), characterized by the excessive accumulation of hepatic triglycerides (TGs), has become a worldwide chronic liver disease. But efficient therapy keeps unsettled. Our previous works show that geniposide and chlorogenic acid combination (namely the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Xin, Xin, Liu, Qian, Tian, Hua-Jie, Peng, Jing-Hua, Zhao, Yu, Hu, Yi-Yang, Feng, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129574/
https://www.ncbi.nlm.nih.gov/pubmed/34017254
http://dx.doi.org/10.3389/fphar.2021.653641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129574/
https://www.ncbi.nlm.nih.gov/pubmed/34017254
http://dx.doi.org/10.3389/fphar.2021.653641

Ejemplares similares